ALBBYOTCHealthcare · Medical - Pharmaceuticals

Alibaba Health Information Technology Limited

$11.16+0.00%(+$0.00)

TickerSpark Score

74/100

Solid

Valuation

Profitability

Growth

100

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALBBY research report →

52-Week Range21% of range

Low $8.95

Current $11.16

High $19.45

Companywww.alihealth.cn

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall. com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform.

CEO: Difan Shen
IPO: 2019
Employees: 1,422
HQ: Causeway Bay, HK

Price Chart

-20.29% · this period

Valuation

Market Cap: $8.99B
P/E: 21.06
P/S: 1.08
P/B: 3.08
EV/EBITDA: 22.74
Div Yield: 0.00%

Profitability

Gross Margin: 23.94%
Op Margin: 5.00%
Net Margin: 5.14%
ROE: 15.30%
ROIC: 12.14%

Growth & Income

Revenue: $33.19B · 8.47%
Net Income: $1.88B · 30.97%
EPS: $2.40 · 34.83%
Op Income: $1.78B
FCF YoY: 0.00%

Performance & Tape

52W High: $19.45
52W Low: $8.95
50D MA: $12.37
200D MA: $14.67
Beta: 1.59
Avg Volume: 47

Get TickerSpark's AI analysis on ALBBY

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime